Received date: 2018-06-29
Revised date: 2018-10-08
Online published: 2018-11-06
Supported by
Supported by the Ministry of Science and Technology of China(2016YFC0900300);the National Natural Science Foundation of China(31500659);the National Natural Science Foundation of China(31770872);the Youth Innovation Promotion Association(CAS 2018133)
Epigenetic modifications include the chemical modifications on DNA, RNA and proteins characterized by altered gene expression and function without any changes in the gene sequence. In addition to well-established DNA and protein epigenetic modifications, the reversible RNA methylation has led the third wave of studies in the epigenetic field. RNA has more than 100 chemical modifications, among which methylation is the major type. The identification of catalyzing enzymes for RNA methylation and the development of high-throughput detection technologies for RNA modification at the transcriptomic level are the prerequisites for revealing the regulatory role of RNA methylation in gene expression and biological functions. In this review, we summarize the recent frontier in RNA methylation-mediated epitranscriptomics from our and other laboratories, with emphasis on the discoveries of RNA modification demethylase , methyltransferase and binding protein as well as the illustration of regulatory roles of RNA methylation modification in hematopoietic stem cell differentiation, spermatogenesis, brain development and other pivotal life processes. These findings have shown that RNA methylation is just as reversible as DNA methylation, and opened up a novel field in RNA methylation-mediated epitranscriptomics, which appends a new layer of epigenetic regulation to the central genetic dogma.
Ying Yang,Yusheng Chen,Baofa Sun,Yungui Yang . RNA methylation: regulations and mechanisms[J]. Hereditas(Beijing), 2018 , 40(11) : 964 -976 . DOI: 10.16288/j.yczz.18-175
| [1] | Yang Y, Hsu PJ, Chen YS, Yang YG . Dynamic transcriptomic m 6A decoration: writers, erasers, readers and functions in RNA metabolism . Cell Res, 2018,28(6):616-624. | |||
| [2] | Frye M, Harada BT, Behm M, He C . RNA modifications modulate gene expression during development. Science, 2018,361(6409):1346-1349. | |||
| [3] | Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT, Parker BJ, Suter CM, Preiss T . Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res, 2012,40(11):5023-5033. | |||
| [4] | Edelheit S, Schwartz S, Mumbach MR, Wurtzel O, Sorek R . Transcriptome-wide mapping of 5-methylcytidine RNA modifications in bacteria, archaea, and yeast reveals m 5C within archaeal mRNAs . PLoS Genet, 2013,9(6):e1003602. | |||
| [5] | Yang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, Li A, Wang X, Bhattarai DP, Xiao W, Sun HY, Zhu Q, Ma HL, Adhikari S, Sun M, Hao YJ, Zhang B, Huang CM, Huang N, Jiang GB, Zhao YL, Wang HL, Sun YP, Yang YG . 5-methylcytosine promotes mRNA export-NSUN2 as the methyltransferase and ALYREF as an m 5C reader . Cell Res, 2017,27(5):606-625. | |||
| [6] | David R, Burgess A, Parker B, Li J, Pulsford K, Sibbritt T, Preiss T, Searle IR . Transcriptome-wide mapping of RNA 5-methylcytosine in Arabidopsis mRNAs and noncoding RNAs. Plant Cell, 2017,29(3):445-460. | |||
| [7] | Amort T, Rieder D, Wille A, Khokhlova-Cubberley D, Riml C, Trixl L, Jia XY, Micura R, Lusser A . Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain. Genome Biol, 2017,18(1):1. | |||
| [8] | Desrosiers R, Friderici K, Rottman F . Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA, 1974,71(10):3971-3975. | |||
| [9] | Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T, Pan T, Yang YG, He C . N 6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol , 2011,7(12):885-887. | |||
| [10] | Mauer J, Luo X, Blanjoie A, Jiao X, Grozhik AV, Patil DP, Linder B, Pickering BF, Vasseur JJ, Chen Q, Gross SS, Elemento O, Debart F, Kiledjian M, Jaffrey SR . Reversible methylation of m 6Am in the 5' cap controls mRNA stability . Nature, 2017,541(7637):371-375. | |||
| [11] | Wei J, Liu F, Lu Z, Fei Q, Ai Y, He PC, Shi H, Cui X, Su R, Klungland A, Jia G, Chen J, He C . Differential m 6A, m 6Am, and m 1A demethylation mediated by FTO in the cell nucleus and cytoplasm . Mol Cell, 2018,71(6):973-985. | |||
| [12] | Su R, Dong L, Li C, Nachtergaele S, Wunderlich M, Qing Y, Deng X, Wang Y, Weng X, Hu C, Yu M, Skibbe J, Dai Q, Zou D, Wu T, Yu K, Weng H, Huang H, Ferchen K, Qin X, Zhang B, Qi J, Sasaki AT, Plas DR, Bradner JE, Wei M, Marcucci G, Jiang X, Mulloy JC, Jin J, He C , Chen J. R-2HG exhibits anti-tumor activity by targeting FTO/ m 6A/MYC/CEBPA signaling. Cell , 2018, 17
/
|